Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/8/2018
SIETES contiene 92469 citas

 
 
 1 a 20 de 323 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Gorelick DA. The effects of cannabis among adults with chronic pain. Ann Intern Med 2018;168:525. [Ref.ID 102602]
2. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
3. Cita con resumen
Sanchis J, Gich I, Pedersen S, Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time?. Chest 2016;150:394-406. [Ref.ID 100596]
4.Tiene citas relacionadas Cita con resumen
Vestbo J, Anderson JA, Brook RD, Calverley PMA, Celli BR, Crim C, Martínez F, Yates J, Newby DE, SUMMIT Investigators. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet 2016;387:1817-26. [Ref.ID 100248]
5.Tiene citas relacionadas Cita con resumen
Brussele G. Vilanterol fluticasone and mortality in comorbid COPD GOLD B. Lancet 2016;387:1791-2. [Ref.ID 100246]
6. Cita con resumen
Plaza Moral V, Giner Donaire J. Terapia inhalada en el asma. Med Clin (Barc) 2016;146:316-23. [Ref.ID 100170]
8.Tiene citas relacionadas Cita con resumen
Ross JS, Redberg RF. On chlorofluorocarbon bans and inhaled albuterol prices. JAMA 2015;175:julio. [Ref.ID 99042]
9. Cita con resumen
Anónimo. Relvar ellipta for asthma. Drug Ther Bull 2014;52:93-6. [Ref.ID 97880]
10. Cita con resumen
Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA 2014;311:193-4. [Ref.ID 97041]
11.
Currie GP, Small I, Douglas G. Long acting beta-2 agonists in adult asthma. BMJ 2013;347:32-5. [Ref.ID 96349]
12.Tiene citas relacionadas
Jenkins C. More than just reassurance on tiotropium safety. N Engl J Med 2013;369:1. [Ref.ID 96098]
13.Tiene citas relacionadas Cita con resumen
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P, for the TIOSPIR Investigators. Tiotropium respimat inhaler and the risk of death in COPD. N Engl J Med 2013;369:1. [Ref.ID 96094]
14. Cita con resumen
Anónimo. Tobramycin in inhalation powder (Tobi Podhaler) for cystic fibrosis. Med Lett Drugs Ther 2013;55:51-2. [Ref.ID 95931]
15. Cita con resumen
van Boven JFM, de Jong-van den Berg LTW, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf 2013;36:231-6. [Ref.ID 95311]
16.
Park HY, Man SFP, Sin DD. Inhaled corticosteroids for chronic obstructive pulmonary disease. BMJ 2012;345:39-45. [Ref.ID 94044]
17.Enlace a cita original Cita con resumen
Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease (review). The Cochrane Collaboration 2012:julio. [Ref.ID 92785]
18. Cita con resumen
Chowdhury BA, Seymour SM, Michele TM, Durmowicz AG, Liu D, Rosebraugh CJ. The risks and benefits of indacaterol - The FDA's review. N Engl J Med 2011;365:2247-9. [Ref.ID 91965]
19. Cita con resumen
Anónimo. Methoxyflurane (Penthrox) for analgesia (doctor’s bag listing). NPS Radar 2010:14 mayo. [Ref.ID 88373]
20. Cita con resumen
Watson R. EC berates drug industry for delays in access to generics. BMJ 2009;339:130. [Ref.ID 86343]
Seleccionar todas
 
 1 a 20 de 323 siguiente >>